Complete video-assisted thoracic lobectomy brings less drainage volume after operation. Early removal of chest tube in CVATL shows feasible and safe and demonstrates that it may reduce postoperative pain and help fast recovery.
Background
This study prospectively investigated the efficacy and radiation dose of ultralow dose computed tomography (CT)‐guided hook‐wire localization (HWL) at 100 kV with tin filtration (100Sn kV) for small solitary pulmonary nodules.
Methods
All HWL procedures were performed on a third generation dual‐source CT system. Eighty‐eight consecutive patients undergoing CT‐guided HWL were randomly assigned to standard dose CT (Group A:
n
= 44; reference 110 kV and 50 mA) or ultralow dose CT (Group B:
n
=44;
100
Sn kV and 96 mA) protocols. The technical success rate, complications, subjective image quality, and radiation dose were compared between the groups.
Results
The mean volume CT dose index and total dose‐length product were significantly lower in Group B compared to Group A (0.32 mGy vs. 3.2 ± 1.1 mGy and 12.1 ± 0.97 mGy‐cm vs. 120 ± 40.6 mGy‐cm;
P
< 0.001). The effective dose in Group B was significantly lower than in Group A (0.17 ± 0.01 mSv vs. 1.68 ± 0.57 mSv, ‐89.8%;
P
< 0.001). The technical success rates were 100% for both groups. There were no significant differences in complication rates between the protocols (
P
> 0.05). The image quality of ultralow dose CT met the requirements for HWL procedure.
Conclusion
Ultralow dose CT‐guided HWL of solitary pulmonary nodules performed at
100
Sn kVp spectral shaping significantly reduced the radiation dose compared to standard dose CT, with high technical success and acceptable patient safety.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.